BeOne Medicines Ltd. (ONC) Madison Wilson January 19, 2026 11:38 am ⚠️ No article content returned. Share on: Written by: Madison Wilson Latest Company News Oncimmune Holdings receives Queen’s Award for Enterprise in Innovation 2022 April 21, 2022 Oncimmune Holdings report two further ImmunoINSIGHTS contracts signed April 8, 2022 Oncimmune Holdings follow-on contract signed with leading US medical research organisation March 7, 2022 Oncimmune ImmunoINSIGHTS contract signed with leading top 10 global pharmaceutical company March 4, 2022 Oncimmune go-to-market partnership with Synexa Life Sciences BV March 1, 2022 Oncimmune’s growing pipeline supporting improved performance and realisation of value February 28, 2022
Oriole Resources Mbe Gold Resource Jumps to 1.66 Million Ounces as District-Scale Potential Builds (video) 23 July 2026
CMC Markets: Why Simpler Technology and Global Reach Could Drive Its Next Retail Growth Phase (video) 23 July 2026
Biotech Growth Trust: The biotech rebound powered by innovation, valuations and pharma’s patent cliff 8 July 2026
CMC Markets FY26 Presentation: The Platform Is Built, The Partnerships Are In Place, Now We Scale 12 June 2026
Cerillion Investor Presentation. Substantial Pipeline. Stronger Competitive Position 26 December 2025
RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield 4 December 2025
CMC Markets Presentation: API-Driven Growth Surges as Westpac Deal Ignites Strategic Shift 2 December 2025
Fidelity Emerging Markets outperforms as technology exposure rises highlighted in latest research (LON:FEML) 30 July 2026
Pharos Energy reports high production, strong cash position and further Vietnam drilling progress, Auctus Advisors 20 July 2026
Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover 13 July 2026
Fidelity Emerging Markets outperforms as technology exposure rises highlighted in latest research (LON:FEML) 30 July 2026
SSP GROUP PLC (SSPG.L) Stock Analysis: Evaluating the 15.95% Potential Upside for Investors 30 July 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Navigating a 28% Potential Upside Amid Challenging Valuations 30 July 2026
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook & Dividend Yield Insights for Savvy Investors 30 July 2026
Softcat PLC (SCT.L) Stock Analysis: A Solid Buy with Robust Revenue Growth in the Technology Sector 30 July 2026
Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover 13 July 2026
